Aeovian Pharmaceuticals

Berkeley, CA · Founded 2012 · Privately Held (backing)

Developer of biotechnology therapies intended to address inflammatory and degenerative diseases. Aeovian Pharmaceuticals is based in Berkeley, CA and was founded in 2012. It was valued at $172 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $143 million across 3 recorded rounds; the latest was a $55 million later-stage round in Nov 2025.

PMV mark · valuation
$172.0M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$143.2M
Last round
Later Stage VC
Nov 2025

Who backs Aeovian Pharmaceuticals?

22 investors
InvestorType
FJ LabsVenture capital
United States Department of War—
TA VenturesVenture capital
b2ventureVenture capital
Foresite CapitalVenture capital
Wilson Sonsini Goodrich & RosatiOther
venBioVenture capital
Felix Jahn InvestmentsVenture capital
TruVenturoFamily office
3e Capital GroupFamily office
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Aeovian Pharmaceuticals investors

22 investors are on record for Aeovian Pharmaceuticals, including FJ Labs, United States Department of War, TA Ventures and b2venture. By type, the record holds 6 venture capital firms and 2 family offices. The later-stage round in Nov 2025 drew 13 investors.

Free account
More of Aeovian Pharmaceuticals with a free account
  • ·The complete investor list: 22 names
  • ·Watch Aeovian Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like Aeovian Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View